Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01972685 · ClinicalTrials.gov registry record · NA

Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD)

A NA study of Interstitial Lung Disease, sponsored by Duke University.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT01972685: Completed NA study of Interstitial Lung Disease, sponsored by Duke University.

NCT01972685 is a NA study of Interstitial Lung Disease that has completed, run by Duke University. The registered enrollment target is 14 participants, below the 566-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01972685, a NA study of Interstitial Lung Disease, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to compare the sample size, architectural preservation and diagnostic yield of bronchoscopic cryo-probe transbronchial lung biopsy (C-TBBx) to bronchoscopic standard transbronchial lung biopsy (S-TBBx) and Video-Assisted Thoracoscopic Surgery (VATS) lung biopsy for the diagnosis of interstitial lung disease (ILD).

Primary Outcome

The number and size of all biopsies, architectural preservation of the airways/alveoli, and pathological diagnosis will be reported by the pathologist. Diagnostic yield will be calculated for each biopsy technique and compared.

Conditions Studied

Interstitial Lung Disease

Interventions

  • PROCEDURE Cryobiopsy biopsy
  • PROCEDURE Transbronchial Biopsy
  • PROCEDURE VATS biopsy

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2013-06
Est. Completion 2018-03-30
Phase NA
Duke University

1,725 total trials

What the finished NCT01972685 record still lists

NCT01972685 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 566-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Interstitial Lung Disease appearing as the primary indexed condition, and to 3 interventions - of which Cryobiopsy biopsy is the first listed.

NCT01972685 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01972685 about?

NCT01972685 is a clinical study titled "Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD)". The objective of this study is to compare the sample size, architectural preservation and diagnostic yield of bronchoscopic cryo-probe transbronchial lung biopsy (C-TBBx) to bronchoscopic standard transbronchial lung biopsy (S-TBBx) and Video-Assisted Thoracoscopic Surgery (VATS) lung biopsy for the...

What is the current status of trial NCT01972685?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2013-06. Estimated completion is 2018-03-30.

What conditions does trial NCT01972685 study?

This clinical trial studies the following conditions: Interstitial Lung Disease.

What interventions are being tested in trial NCT01972685?

The interventions under investigation include: Cryobiopsy biopsy (PROCEDURE), Transbronchial Biopsy (PROCEDURE), VATS biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT01972685?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01972685 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Interstitial Lung Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01972685's enrollment target sits among peer trials

14 34th of 36 higher than 3 of 36 other Interstitial Lung Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Interstitial Lung Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01972685, the US trial registry maintained by the National Library of Medicine. NCT01972685 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.